Purpose of the development: For the treatment and prevention of thrombotic, cardiovascular, cerebral, cerebrovascular diseases, pathologies of pregnancy and other diseases.

Recommended application field: Medicine.

Technical characteristic: The main components are choline chloride, vitamin C (ascorbic acid), vitamin B6, folic acid (vitamin B9), vitamin B12 and excipients - fillers. Capsules with a content weight of 400 mg + 7.5%.

Advantages over analogues: Tests on rats showed that the use of Alfacognitin contributed to an increase in locomotor activity, a decrease in anxiety, an improvement in recognition, an interest in new social contacts and compensation for memory impairments.

The development stage readiness: Tested experimental exploitation order

Description of the development:
()
This is a dietary supplement that contains a complex of folic acid, vitamins B12, B6 and B1 with choline in the optimal ratio, maximizes the reduction of homocysteine levels and enhances the antioxidant effect of the drug.

Information about newness of the development:
there are inventor's certificate -- 1 items

corresponds technical description
Ready for implementation

Possibility of transfer abroad:
Realization of finished commodity
Joint production, sale, exploitation

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua